HFE gene mutations in alcoholic and virus-related cirrhotic patients with hepatocellular carcinoma

American Journal of Gastroenterology

Volumn 97, Issue 4, 2002, Pages 1016-1021

  Lauret, Eugenia ^a   Rodríguez, Manuel ^a   González, Segundo ^b   Linares, Antonio ^a   López Vázquez, Antonio ^a   Martínez Borra, Jesús ^a   Rodrigo, Luis ^a   López Larrea, Carlos ^a  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^b UNIVERSITY OF OVIEDO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HFE PROTEIN; IRON;

ADULT; AGED; ALCOHOL LIVER CIRRHOSIS; ARTICLE; CANCER RISK; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; HEMOCHROMATOSIS; HEPATITIS B; HEPATITIS C; HETEROZYGOTE; HUMAN; HUMAN TISSUE; IRON OVERLOAD; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPATITIS B; HEPATITIS C; HETEROZYGOTE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; LIVER CIRRHOSIS; LIVER CIRRHOSIS, ALCOHOLIC; LIVER NEOPLASMS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MUTATION; RISK FACTORS;

EID: 0036123930     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(01)04115-6     Document Type: Article

References (31)

1. Hepatocellular carcinoma
2. Hepatocellular carcinoma
3. Treatment of hepatocellular carcinoma associated with cirrhosis in the era of liver transplantation
4. Hepatocellular carcinoma
5. Iron in liver diseases other than hemochromatosis
6. Iron overload in viral and alcoholic liver disease
7. Hemosiderosis in cirrhosis: A study of 447 native livers
8. End-stage liver disease without hemochromatosis associated with elevated hepatic iron index
9. Survival and causes of death in cirrhotic and in non-cirrhotic patients with primary hemochromatosis
10. Body iron stores and the risk of cancer
11. Iron and neoplasia
12. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis
13. Haemochromatosis, and HLA-H
14. Haemochromatosis, and HLA-H
15. Heterogeneity of hemochromatosis in Italy
16. Prevalence of the Cys282Tyr and His63Asp HFE gene mutations in Spanish patients with hereditary hemochromatosis and in controls
17. Genetic irony beyond haemochromatosis: Clinical effects of HLA-H mutations
18. Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in North America
19. Non-alcoholic steatohepatitis, and iron: Increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis
20. A simple salting out procedure for extracting DNA from human nucleated cells
21. Global prevalence of putative haemochromatosis mutation
22. The relation of iron status and hemochromatosis gene mutations in patients with chronic hepatitis C
23. Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C
24. Heterozygotes for HFE mutations have no increased risk of advanced alcoholic liver disease
25. Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis
26. Extremely elevated serun ferritin levels in a university hospital: Associated diseases and clinical significance
27. Increased liver iron stores in patients with hepatocellular carcinoma developed on a non-cirrhotic liver
28. Prevalence of the haemochromatosis gene mutation in non-cirrhotic liver with hepatocellular carcinoma
29. Increased incidence of HFE C282Y mutations in patients with iron overload and hepatocellular carcinoma developed in non-cirrhotic liver
30. Iron, oxidative stress and liver fibrogenesis
31. Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis